“Minimally Invasive Dermal Microdialysis Measures Miltefosine Levels in Post Kala-azar Dermal Leishmaniasis Patient Skin, Offering Treatment Regimen Optimization”

https://pubmed.ncbi.nlm.nih.gov/38114040

This study demonstrates the use of minimally invasive dermal microdialysis to measure miltefosine drug levels in the skin of a Post kala-azar dermal leishmaniasis (PKDL) patient, offering a tool for optimizing treatment regimens.